References
- Pattee GL, Plowman EK, (Focht) Garand KL, Costello J, Brooks BR, Berry JD, et al. Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosis. Muscle Nerve. 2019;59:531.
- Green JR, Yunusova Y, Kuruvilla MS, Wang J, Pattee GL, Synhorst L, et al. Bulbar and speech motor assessment in ALS: challenges and future directions. Amyotroph La Scl Fr. 2013;14:494–500.
- Yunusova Y, Plowman EK, Green JR, Barnett C, Bede P. Clinical measures of bulbar dysfunction in ALS. Front Neurol. 2019;10:106.
- Perry BJ, Martino R, Yunusova Y, Plowman EK, Green JR. Lingual and jaw kinematic abnormalities precede speech and swallowing impairments in ALS. Dysphagia. 2018;33:840–47.
- Zemlin WR. Speech and hearing science: anatomy and physiology. 4th ed., London, UK: Pearson; 1998.
- Rong P, Yunusova Y, Wang J, Green JR. Predicting early bulbar decline in Amyotrophic Lateral Sclerosis: a speech subsystem approach. Behav Neurol. 2015.
- Rong P, Yunusova Y, Wang J, Zinman L, Pattee GL, Berry JD, et al. Predicting speech intelligibility decline in amyotrophic lateral sclerosis based on the deterioration of individual speech subsystems. PLoS One. 2016;11:e0154971.
- Rong P, Yunusova Y, Richburg B, Green JR. Automatic extraction of abnormal lip movement features from the alternating motion rate task in amyotrophic lateral sclerosis. Int J Speech-Lang Pa. 2018;20:610–23.
- Rong P, Y, Yunusova JR. Green Speech intelligibility decline in individuals with fast and slow rates of ALS progression. In: Interspeech. Dresden, Germany: Proceedings of Interspeech; 2015.
- Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
- Yunusova Y, Graham NL, Shellikeri S, Phuong K, Kulkarni M, Rochon E, et al. Profiling speech and pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Plos One. 2016;11:e0147573.
- Ball L, Beukelman D, Pattee GL. Timing of speech deterioration in people with amyotrophic lateral sclerosis.J Med Speech Lang Pathol. 2002;10(4):231–235.
- Yorkston KM, Strand EA, Miller R, Smith K. Speech deterioration in amyotrophic lateral sclerosis: implications for the timing of intervention. J Med Speech-Lang Pa. 1993;1:35–46.
- Stergiou N, Decker LM. Human movement variability, nonlinear dynamics, and pathology: is there a connection? Hum Movement Sci. 2011;30:869–88.
- Simon NG, Turner MR, Vucic S, Al-Chalabi A, Shefner J, Lomen-Hoerth C, et al. Quantifying disease progression in amyotrophic lateral sclerosis. Ann Neurol. 2014;76: 643–657.
- Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66:265–7.
- Kollewe K, Mauss U, Krampfl K, Petri S, Dengler R, Mohammadi B. ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci. 2008;275:69–73.